UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics, three decades ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

On new antibiotic medicine tested by Wockhart, Wockhart Limited Executive Director Dr. Huzaifa Khorakiwala said, “Our ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

M ass firings hit U.S. health agencies over the past week, but disruptions to the nation’s medical research system have been ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, applauded the discovery. "Artificial intelligence promises to improve new drug targets ...